At the news
? NEUTRALIMPACT 4/10 COURT-RULING filed Mar 1, 2026 at 19:00 ET
In the Generic Pharmaceuticals MDL, Judge Rufe partially granted and partially denied Epic Pharma's motions to dismiss antitrust claims. The Kroger Co. is among the eight plaintiffs whose complaints against Epic were found to sufficiently allege a conspiracy to fix prices of Ursodiol, those claims survive. Three other complaints (CVS, HCSC, Molina) were dismissed against Epic for insufficient pleading. For Kroger, the ruling removes near-term dismissal risk and allows the case to proceed toward discovery, but no damages have been awarded and the litigation remains in early stages.
- Kroger's complaint against Epic Pharma for Ursodiol price-fixing conspiracy survives Epic's motion to dismiss
- The court found Kroger's complaint sufficiently alleged parallel conduct, motive, action against self-interest, and traditional conspiracy (meetings/communications between Epic, Lannett, and Actavis)
- Epic raised Ursodiol price >1000% (from $0.45 to $5.10 per 300-mg unit) on May 6, 2014, days after Lannett entered at $5.11
- Three other complaints (CVS, HCSC, Molina) were dismissed against Epic for failing to allege specific Epic conduct
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access